Dr David Clark Wohlrabe, DDS | |
406 Main St. Nw, Baudette, MN 56623-0546 | |
(218) 634-2389 | |
(218) 634-2381 |
Full Name | Dr David Clark Wohlrabe |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 406 Main St. Nw, Baudette, Minnesota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730184797 | NPI | - | NPPES |
81132WOH | Other | MN | BLUE CROSS BLUE SHIELD MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | D9678 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr David Clark Wohlrabe, DDS Po Box 546, Baudette, MN 56623-0546 Ph: (218) 634-2389 | Dr David Clark Wohlrabe, DDS 406 Main St. Nw, Baudette, MN 56623-0546 Ph: (218) 634-2389 |
News Archive
UK based MR Solutions presented a simultaneous 7T PET/MRI preclinical imaging system optimized for nanoparticle imaging to the first joint annual congress of the French Nanomedicine Society (SFNano), and the French national Competency Cluster in Nanoscience C'Nano which was held in Dijon in early December.
Nektar Therapeutics reported partner AstraZeneca today announced that MOVENTIG (naloxegol) has been granted Marketing Authorisation by the European Commission for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).
Spring weather signals the start of many outdoor activities as people of all ages eagerly embrace the change in weather. Paul Prinz, MD, orthopaedic surgeon at Gottlieb Memorial Hospital, part of Loyola University Health System says, "Broken bones and fractures occur year 'round but the change in seasons always creates an increase of patients in our offices."
biospace med announced today that it has received 510(k) clearance from the FDA to market the Company's sterEOS 2D/3D workstation for pediatric use in spine applications. The Company's EOS ultra-low-dose imager previously has been FDA-cleared for use in pediatrics and adults, while sterEOS has previously been FDA-cleared for adult use in spine.
› Verified 9 days ago